![](/img/cover-not-exists.png)
Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy
Dragomir P Zubac, Tore Wentzel-Larsen, Tomas Seidal, Leif BostadVolume:
10
Language:
english
DOI:
10.1186/1471-2490-10-20
Date:
December, 2010
File:
PDF, 383 KB
english, 2010